SCHEMBL20182275

SCHEMBL20182275

CCC(/C(=C/Nc1ccc(F)c(F)c1)N=N)n1cc(-c2cnc(OC)c(F)c2)c2c(N)ncnc21

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.36
ABL1 P00519 3/20 0.36
ABL2 P42684 3/20 0.36
PIK3CD O00329 1/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
PIK3CG P48736 1/20 0.35
PRKDC P78527 1/20 0.35
KDR P35968 5/20 0.35
TEK Q02763 5/20 0.35
SRC P12931 4/20 0.35
NEK7 Q8TDX7 2/20 0.34
FLT3 P36888 2/20 0.33
AXL P30530 1/20 0.33
RET P07949 1/20 0.33
LCK P06239 3/20 0.33
EIF2AK3 Q9NZJ5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20182222 0.91 AXL (0.34) EGFRABL1ABL2PIK3CDPIK3CA
SCHEMBL20182271 0.90 CFTR (0.35) EGFRABL1ABL2PIK3CDPIK3CA
SCHEMBL20182292 0.90 NEK7 (0.37) EGFRABL1ABL2PIK3CDPIK3CA
SCHEMBL20182225 0.89 CFTR (0.39) EGFRABL1ABL2PIK3CDPIK3CA
SCHEMBL20182235 0.83 EIF2AK3 (0.34) EGFRABL1ABL2PIK3CDPIK3CA
SCHEMBL20182191 0.82 ALK (0.34) EGFRABL1ABL2KDRTEK
SCHEMBL20182289 0.82 NTRK1 (0.36) EGFRABL1ABL2PIK3CDPIK3CA
SCHEMBL20181882 0.81 EGFR (0.42) EGFRABL1ABL2PIK3CDPIK3CA
SCHEMBL20182194 0.81 EIF2AK3 (0.36) EGFRABL1ABL2PIK3CDPIK3CA
SCHEMBL20182265 0.80 NTRK1 (0.36) EGFRABL1ABL2KDRNEK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed